NEUROSENSE THERAPEUTICS LTD (NRSN) Stock Price & Overview
NASDAQ:NRSN • IL0011809592
Current stock price
The current stock price of NRSN is 0.76 USD. Today NRSN is up by 1.33%. In the past month the price decreased by -11.18%. In the past year, price decreased by -23.74%.
NRSN Key Statistics
- Market Cap
- 25.384M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.54
- Dividend Yield
- N/A
NRSN Stock Performance
NRSN Stock Chart
NRSN Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to NRSN. When comparing the yearly performance of all stocks, NRSN is a bad performer in the overall market: 81.86% of all stocks are doing better.
NRSN Earnings
NRSN Forecast & Estimates
9 analysts have analysed NRSN and the average price target is 8.54 USD. This implies a price increase of 1024.01% is expected in the next year compared to the current price of 0.76.
NRSN Groups
Sector & Classification
NRSN Financial Highlights
Over the last trailing twelve months NRSN reported a non-GAAP Earnings per Share(EPS) of -0.54. The EPS increased by 25.92% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -1037.6% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
NRSN Ownership
NRSN Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 14.48 | 384.559B | ||
| AMGN | AMGEN INC | 15.45 | 189.672B | ||
| GILD | GILEAD SCIENCES INC | 15.93 | 173.017B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 23.09 | 113.435B | ||
| REGN | REGENERON PHARMACEUTICALS | 16.65 | 81.684B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 44.02 | 43.88B | ||
| INSM | INSMED INC | N/A | 35.247B | ||
| NTRA | NATERA INC | N/A | 28.345B | ||
| BIIB | BIOGEN INC | 11.42 | 26.906B | ||
| UTHR | UNITED THERAPEUTICS CORP | 19.23 | 25.99B | ||
| MRNA | MODERNA INC | N/A | 20.063B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 19.272B | ||
| INCY | INCYTE CORP | 12.32 | 18.731B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About NRSN
Company Profile
Neurosense Therapeutics Ltd. is a clinical-stage biotechnology company, which engages n the discovery and development of targeted therapeutics for neurodegenerative diseases. The firm is active in field of drug development and treatment offers Amyotrophic Lateral Sclerosis (ALS) patients, as well as other neurodegenerative diseases. The firm's lead product candidate, PrimeC, is an oral formulation of a fixed dose combination composed of a specific ratio of drugs. In addition to PrimeC, the Company has initiated research and development efforts in Alzheimer's disease and Parkinson's disease
Company Info
IPO: 2021-12-09
NEUROSENSE THERAPEUTICS LTD
11 Hamenofim St., Building B
Herzliya IL
Employees: 15
Phone: 97297996183
NEUROSENSE THERAPEUTICS LTD / NRSN FAQ
Can you describe the business of NEUROSENSE THERAPEUTICS LTD?
Neurosense Therapeutics Ltd. is a clinical-stage biotechnology company, which engages n the discovery and development of targeted therapeutics for neurodegenerative diseases. The firm is active in field of drug development and treatment offers Amyotrophic Lateral Sclerosis (ALS) patients, as well as other neurodegenerative diseases. The firm's lead product candidate, PrimeC, is an oral formulation of a fixed dose combination composed of a specific ratio of drugs. In addition to PrimeC, the Company has initiated research and development efforts in Alzheimer's disease and Parkinson's disease
What is the current price of NRSN stock?
The current stock price of NRSN is 0.76 USD. The price increased by 1.33% in the last trading session.
What is the dividend status of NEUROSENSE THERAPEUTICS LTD?
NRSN does not pay a dividend.
What is the ChartMill rating of NEUROSENSE THERAPEUTICS LTD stock?
NRSN has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
What is the Price/Earnings (PE) ratio of NEUROSENSE THERAPEUTICS LTD (NRSN)?
NEUROSENSE THERAPEUTICS LTD (NRSN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.54).
What is the Short Interest ratio of NEUROSENSE THERAPEUTICS LTD (NRSN) stock?
The outstanding short interest for NEUROSENSE THERAPEUTICS LTD (NRSN) is 1.82% of its float.